Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas D James

Showing results (21-30 of 198) with videos related to

Pageof 20
Sort By:
Anticancer Research|February 11, 2015
Predictive factors for response to abiraterone in metastatic castration refractory prostate cancerMehran Afshar, Fawaz Al-Alloosh, Sarah Pirrie, et al.
European Urology|July 18, 2021
Should Patients with High-risk Localised or Locally Advanced Prostate Cancer Receive Abiraterone Acetate in Addition to Androgen Deprivation Therapy? Update on a Planned Analysis of the STAMPEDE TrialGerhardt Attard, Louise C Brown, Noel W Clarke, et al.
BJU International|April 14, 2025
Improving the pathway to correct treatment for patients with muscle-invasive bladder cancer: exploring the myths around the BladderPath trialRichard T Bryan, Prashant Patel, Steven J Kennish, et al.
International Journal of Cancer|September 5, 2024
The Man Van: A pilot study of using mobile targeted case-finding to address health inequalities in prostate cancerMasood Moghul, Amina Tran, Fionnuala Croft, et al.
BJU International|February 12, 2005
Molecular pathways in bladder cancer: part 1Richard T Bryan, Syed A Hussain, Nicholas D James, et al.
European Urology|May 31, 2021
Reply to Santhanam Sundar and Paul Symonds' Letter to the Editor re: Syed A. Hussain, Nuria Porta, Emma Hall, et al. Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial. Eur Urol 2021;79:307-15Syed A Hussain, Nuria Porta, Emma Hall, et al.
Lancet (London, England)|September 10, 2019
Radiotherapy for metastatic prostate cancer-Authors' replyChristopher C Parker, Nicholas D James, Christopher D Brawley, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 28, 2011
Reflections on attempted Anglo-Japanese collaboration on STAMPEDE: a randomized controlled trial for men with prostate cancerMatthew R Sydes, Shin Egawa, Karen Sanders, et al.
BJU International|October 2, 2009
Biomarkers in bladder cancerRichard T Bryan, Maurice P Zeegers, Nicholas D James, et al.
Experimental Neurology|June 6, 2015
Chondroitinase gene therapy improves upper limb function following cervical contusion injuryNicholas D James, Jessie Shea, Elizabeth M Muir, et al.
Pageof 20

Showing results (21-30 of 198) with videos related to

Sort By:
Pageof 20
Anticancer Research|February 11, 2015
Predictive factors for response to abiraterone in metastatic castration refractory prostate cancerMehran Afshar, Fawaz Al-Alloosh, Sarah Pirrie, et al.
European Urology|July 18, 2021
Should Patients with High-risk Localised or Locally Advanced Prostate Cancer Receive Abiraterone Acetate in Addition to Androgen Deprivation Therapy? Update on a Planned Analysis of the STAMPEDE TrialGerhardt Attard, Louise C Brown, Noel W Clarke, et al.
BJU International|April 14, 2025
Improving the pathway to correct treatment for patients with muscle-invasive bladder cancer: exploring the myths around the BladderPath trialRichard T Bryan, Prashant Patel, Steven J Kennish, et al.
International Journal of Cancer|September 5, 2024
The Man Van: A pilot study of using mobile targeted case-finding to address health inequalities in prostate cancerMasood Moghul, Amina Tran, Fionnuala Croft, et al.
BJU International|February 12, 2005
Molecular pathways in bladder cancer: part 1Richard T Bryan, Syed A Hussain, Nicholas D James, et al.
European Urology|May 31, 2021
Reply to Santhanam Sundar and Paul Symonds' Letter to the Editor re: Syed A. Hussain, Nuria Porta, Emma Hall, et al. Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial. Eur Urol 2021;79:307-15Syed A Hussain, Nuria Porta, Emma Hall, et al.
Lancet (London, England)|September 10, 2019
Radiotherapy for metastatic prostate cancer-Authors' replyChristopher C Parker, Nicholas D James, Christopher D Brawley, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 28, 2011
Reflections on attempted Anglo-Japanese collaboration on STAMPEDE: a randomized controlled trial for men with prostate cancerMatthew R Sydes, Shin Egawa, Karen Sanders, et al.
BJU International|October 2, 2009
Biomarkers in bladder cancerRichard T Bryan, Maurice P Zeegers, Nicholas D James, et al.
Experimental Neurology|June 6, 2015
Chondroitinase gene therapy improves upper limb function following cervical contusion injuryNicholas D James, Jessie Shea, Elizabeth M Muir, et al.
Pageof 20